Q32 Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	89.08	25.62	43.89	32.25
Cash & Short-Term Investments	89.08	25.62	43.89	32.25
Cash Growth	145.69%	-41.64%	36.11%	-
Other Receivables	0.56	0.76	1.06	0.91
Receivables	0.56	0.76	1.06	0.91
Prepaid Expenses	4.03	2.26	1.75	0.77
Other Current Assets	0.23	0.08	0.15	0.07
Total Current Assets	93.9	28.72	46.85	34
Property, Plant & Equipment	7.36	8.08	9.17	0.2
Other Long-Term Assets	0.69	10.26	5.76	0.95
Total Assets	104.54	47.06	61.77	35.15
Accounts Payable	1.26	3.47	1.44	2.68
Accrued Expenses	7.85	8.91	8.46	4.54
Current Portion of Long-Term Debt	1.53	0.88	32.4	-
Current Portion of Leases	1.03	0.54	0.47	-
Current Income Taxes Payable	0.04	0.32	0.57	-
Current Unearned Revenue	-	-	14.53	-
Total Current Liabilities	14.38	14.11	57.87	7.22
Long-Term Debt	11.07	43.18	5.07	4.97
Long-Term Leases	5.79	6.25	6.79	-
Long-Term Unearned Revenue	-	-	11.32	-
Other Long-Term Liabilities	55	55	-	0.73
Total Liabilities	86.25	118.53	81.04	12.92
Common Stock	0	0	0	0
Additional Paid-In Capital	238.92	4.16	2.63	1.32
Retained Earnings	-220.63	-187.08	-133.34	-90.53
Total Common Equity	18.3	-182.92	-130.71	-89.21
Shareholders' Equity	18.3	-71.48	-19.27	22.24
Total Liabilities & Equity	104.54	47.06	61.77	35.15
Total Debt	22.1	50.84	44.73	4.97
Net Cash (Debt)	66.97	-25.22	-0.84	27.28
Net Cash Per Share	5.05	-3.48	-0.12	4.22
Filing Date Shares Outstanding	12.18	11.93	7.14	6.47
Total Common Shares Outstanding	12.14	7.47	7.14	6.47
Working Capital	79.52	14.61	-11.01	26.78
Book Value Per Share	1.51	-24.48	-18.31	-13.79
Tangible Book Value	18.3	-182.92	-130.71	-89.21
Tangible Book Value Per Share	1.51	-24.48	-18.31	-13.79
Machinery	1.82	1.81	1.81	0.31
Leasehold Improvements	1	0.94	0.94	-

Source: S&P Capital IQ. Standard template. Financial Sources.